Unichem Laboratories holds 63rd AGM on Aug 11, 2026, approves financial statements.
Unichem Laboratories Limited conducted its 63rd Annual General Meeting on August 11, 2026. The meeting approved audited standalone and consolidated financial statements for the year ended March 31, 2026. Key decisions included the re-appointment of Mr. Pabitrakumar Bhattacharyya as Managing Director and CEO.
The announcement is about a routine annual general meeting and the approval of financial statements, which are standard corporate procedures. No new strategic initiatives or significant financial outcomes were highlighted that would have a major impact on the company.
The announcement details the proceedings of the Annual General Meeting, including the adoption of financial statements and the re-appointment of a director. It is a routine corporate event without significant positive or negative financial implications stated.
Unichem Laboratories Limited held its 63rd Annual General Meeting (AGM) on Tuesday, August 11, 2026, commencing at 3:30 p.m. The meeting was conducted through video conference, adhering to circulars from the Ministry of Corporate Affairs (MCA) and SEBI.
Due to the unavoidable absence of Chairman Dr. Prakash A. Mody, Non-Executive Director Mr. Pranay Godha presided over the meeting. The Chairmen of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders’ Relationship Committee were present, along with all other Directors. Representatives from the Statutory Auditors, N.A. Shah Associates LLP, and Secretarial Auditors & Scrutinizer from Alwyn Jay & Co. also attended.
The meeting transacted business as outlined in the Notice dated May 22, 2026. The audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the Directors' and Auditors' reports, were considered and adopted. Key business included the appointment of a director in place of Mr. Pabitrakumar Bhattacharyya, who retired by rotation and offered himself for re-appointment, and the special business of re-appointing Mr. Pabitrakumar Bhattacharyya as Managing Director and Chief Executive Officer. The remuneration of the Cost Auditors for the year ended March 31, 2027, was also ratified.
Shareholders raised queries and suggestions, which were addressed during the meeting. The Company Secretary confirmed that the Statutory Auditors' Report and the Secretarial Auditor’s report had no qualifications. E-voting, managed through the NSDL platform, remained open for fifteen minutes post-meeting for members who had not yet voted. Mr. Alwyn D’Souza, Practicing Company Secretary, was appointed as the scrutinizer to oversee the e-voting process, with results to be disclosed to stock exchanges and posted on the company website within the stipulated time. The meeting concluded at 4:11 p.m.
What to do with a filing like this
Unichem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Unichem Laboratories Limited. Read the original for the full detail.